What is the current market price of lapatinib?
Lapatinib(Lapatinib) is a targeted therapy drug mainly used to treat human epidermal growth factor receptor type 2 (HER2)-positive breast cancer, especially when patients fail to respond to other treatments. Its mechanism of action is to inhibit the tyrosine kinase activity of HER2 and EGFR (epidermal growth factor receptor), thereby blocking the proliferation signals of tumor cells and improving the therapeutic effect. Lapatinib is often used in combination with other drugs to form combination therapy to enhance the anti-cancer effect.
In China, the original drug lapatinib has been officially launched, but it is not yet included in medical insurance. This situation puts patients under certain pressure in terms of financial burden. The common specifications are 70 tablets in a 0.25g package. Each box sells for about 5,000 to 6,000 yuan. The specific price will vary depending on the region and hospital. Therefore, it is recommended that patients consult the local hospital pharmacy before purchasing to obtain accurate pricing information. This price level is relatively high in the domestic drug market and may affect accessibility for some patients.
In addition to lapatinib sold domestically, there are also many options in the international market. The original drug produced in Türkiye is relatively cheap, priced at more than 2,000 yuan, which provides a relatively economical option for patients who need the drug. In addition, generic drugs from countries such as India and Bangladesh have also received attention, and their prices are usually around 600 yuan. Although these generic drugs are low in price, their ingredients are basically the same as the original drugs at home and abroad, and they can provide patients with effective treatment options.
However, when choosing a drug, several aspects that patients need to pay special attention to include the source of the drug, quality assurance and individualized treatment options. Although generic drugs have obvious advantages in price, you should still consult a professional doctor when choosing to ensure the therapeutic effect and safety.
Reference materials:https://medlineplus.gov/druginfo/meds/a607055.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)